Profil
Robert Letellier founded PharmaGap, Inc. in 1999, where he worked as Director from 2010 to 2012 and AB Biotech, Inc. in 2004, where he is working as President, Chief Executive Officer & Director from 2011.
Mr. Letellier received his undergraduate degree from the University of Sherbrooke.
Postes actifs de Robert Letellier
| Sociétés | Poste | Début |
|---|---|---|
AB Biotech, Inc.
 AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Fondateur | 21/10/2010 |
Anciens postes connus de Robert Letellier
| Sociétés | Poste | Fin |
|---|---|---|
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Fondateur | - |
Formation de Robert Letellier
| University of Sherbrooke | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
AB Biotech, Inc.
AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Health Technology |
